OCTO Shareholder/Stockholder Letter Transcript:
EIGHTCO HOLDINGS INC. 2024 ANNUAL REPORT
Eightco Holdings Inc. Board of Directors and Executive Officers as of December 1, 2025
BOARD OF DIRECTORS
Name
Principal Occupation or Employment
Daniel Ives
Managing Director, Senior Equity Research Analyst, and Global Head of
Technology Research at Wedbush Securities
Chief Executive Officer of Eightco Holdings Inc.
President of Pelago Health
Chief Executive Officer of Enventys
Chief Financial Officer of Cytometric Therapeutics
Kevin O Donnell
Frank Jennings
Louis Foreman
Nicola Caiano
EXECUTIVE OFFICERS
Name
Principal Occupation or Employment
Kevin O Donnell
Brett Vroman
Chief Executive Officer
Chief Financial Officer
This Annual Report contains forward-looking statements. All statements contained in this Annual Report other than statements
of historical fact, including statements regarding our future results of operations and financial position, our business strategy
and plans, and our objectives for future operations, are forward-looking statements. Please read the section of our Annual
Report on Form 10-K entitled Cautionary Note Regarding Forward-Looking Statements for a discussion of the limitations
and risks regarding forward-looking statements made in this Annual Report. These forward-looking statements are subject to
a number of risks, uncertainties and assumptions, including those described in Part I, Item 1A, Risk Factors of our Annual
Report on Form 10-K included herein, which may cause actual results to differ materially from those contained in any forwardlooking statements we may make. We undertake no obligation to revise or publicly release the results of any revision to these
forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place
undue reliance on such forward-looking statements.
12/1/2025 Letter Continued (Full PDF)